Project Number 1UG3NS116921-01 Agency/Funding Organization NINDS Funding Year 2020 View Full Project Details for RNA Targeted Drug Discovery and Development for Parkinson Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 5. Other Proteinopathies a. Alpha-Synuclein Researcher and Organization Principal Investigator MOURADIAN, M. MARAL Principal Investigator First Name M. MARAL Principal Investigator Last Name MOURADIAN Awardee Organization RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL Awardee State New Jersey Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-546: Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3) - Clinical Trial Optional FY Overall Cost $522,761 Funding Organization Agency/Funding Organization NINDS Funding Organization Country United States Program Official CYWIN, CHARLES
